A description of next-step switching versus augmentation practices for outpatients with treatment-resistant major depressive disorder enrolled in an academic specialty clinic

Annals of Clinical Psychiatry

Volumn 17, Issue 3, 2005, Pages 161-165

  Papakostas, George I ^a   Petersen, Timothy J ^a   Green, Cassandra ^a   Iosifescu, Dan V ^a   Yeung, Albert S ^a   Nierenberg, Andrew A ^a   Fava, Maurizio ^a   Posternak, Michael A ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Augmentation; Naturalistic; Non randomized; Resistant; Switch; Treatment

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; LITHIUM; MIRTAZAPINE; MODAFINIL; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL PRACTICE; DISEASE SEVERITY; DRUG RESISTANCE; EXPERIENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; REMISSION; TREATMENT OUTCOME;

ACADEMIC MEDICAL CENTERS; ADULT; AMBULATORY CARE; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PERSONALITY ASSESSMENT; PERSONALITY INVENTORY; PROSPECTIVE STUDIES; RETREATMENT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 23844514341     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: 10.1080/10401230591002129     Document Type: Article

References (17)

1. Fava M, Davidson KG: Definition and epidemiology of treatment-resistant depression. Psychiatric Clinics of North America 1996; 19(2):179-200
2. Petersen T, Dording C, Neault NB, Kornbluh R, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M: A survey of prescribing practices in the treatment of depression. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26(1):177-87
3. Nierenberg AA, Wright EC: "Evolution of remission as the new standard in the treatment of depression." J Clin Psychiatry. 1999; 60(suppl); 22:7-1
4. Fava M, Kaji J: Continuation and maintenance treatments of major depressive disorder. Psych Annals 1994; 42:281-290
5. Mischoulon D, Fava M, Rosenbaum JF: Strategies for augmentation of SSRI treatment: A survey of an academic psychopharmacology practice. Harv Rev Psychiatry 1999; 6(6):322-326
6. Fredman SJ, Fava M, Kienke AS, White CN, Nierenberg AA, Rosenbaum JF: Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: a survey of current "next-step" practices. J Clin Psychiatry 2000; 61(6):403-8
7. Guy W (ed); ECDEU Assessment Manual for Psychopharmacology, revised. DHEWPub. No. (ADM) 76-338. Rockville, MD: National Institute of Mental Health, 1976
8. Fava M: Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003; 53(8):649-59
9. Posternak MA, Zimmerman M: Switching versus augmentation: A prospective, naturalistic comparison in depressed, treatment-resistant patients. J Clin Psychiatry 2001; 62(2):135-42
10. Hylan TR, Meneades L, Crown WH, Sacristan JA, Gilaberte I, Montejo AL: SSRI antidepressant use patterns and their relation to clinical global impression scores: A naturalistic study. J Affect Disord 1999; 52(1-3):111-9
11. Rush AJ, Bose A, Heydorn WE: Naturalistic study of the early psychiatric use of citalopram in the United States. Depress Anxiety 2002; 16(3):121-7
12. Posternak MA, Zimmerman M: Short-term spontaneous improvement rates in depressed outpatients. J Nerv Ment Dis 2000; 188(12):799-804
13. Sporn J, Ghaemi SN, Sambur MR, Rankin MA, Recht J, Sachs GS, Rosenbaum JF, Fava M: Pramipexole augmentation in the treatment of unipolar and bipolar depression: A retrospective chart review. Ann Clin Psychiatry 2000; 12(3):137-40
14. Faries D, Herrera J, Rayamajhi J, DeBrota D, Demitrack M, Potter WZ: The responsiveness of the Hamilton Depression Rating Scale. J Psychiatr Res 2000; 34(1):3-10
15. Fava M, Burt T, Batzar E, Sackeim H: Conditional probability of remission at 8 weeks given early global improvement in major depressive disorder. European Neuropsychopharmacology 2003; 13(4):S214
16. Hamilton M: A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry 1960; 23:56-62
17. First BM, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID UP). Biometrics Research Department, New York State Psychiatric Institute, 1995